MOREPEN LABORATORIES
Back to Balance Sheet
|
MOREPEN LABORATORIES Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹6.98 Cr | ₹2.25 Cr | ₹2.69 Cr | ₹2.48 Cr | - |
What is the latest Deferred Tax Assets / Liabilities ratio of MOREPEN LABORATORIES ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹6.98 Cr |
| Mar2024 | ₹2.25 Cr |
| Mar2023 | ₹2.69 Cr |
| Mar2022 | ₹2.48 Cr |
| Mar2021 | - |
How is Deferred Tax Assets / Liabilities of MOREPEN LABORATORIES Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹6.98 Cr | 210.09 | |
| Mar2024 | ₹2.25 Cr | -16.23 | |
| Mar2023 | ₹2.69 Cr | 8.18 | |
| Mar2022 | ₹2.48 Cr | 0 | |
| Mar2021 | - | - | |
Compare Deferred Tax Assets / Liabilities of peers of MOREPEN LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MOREPEN LABORATORIES | ₹2,679.2 Cr | 1.6% | -5.8% | -40.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹407,791.0 Cr | 1.2% | 4.2% | -10.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹174,885.0 Cr | -0.5% | 8.9% | 10.8% | Stock Analytics | |
| CIPLA | ₹127,930.0 Cr | 0.4% | 3.7% | 8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹121,108.0 Cr | -0% | -2.1% | 6.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,164.0 Cr | 2.2% | -1.8% | -4.4% | Stock Analytics | |
MOREPEN LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MOREPEN LABORATORIES | 1.6% |
-5.8% |
-40.2% |
| SENSEX | 0.9% |
2.5% |
3.7% |
You may also like the below Video Courses